Team introduces new approach in cancer therapy with innovative mechanism-of-action for ferroptosis induction
A team of researchers led by Dr. Marcus Conrad from Helmholtz Munich has discovered a novel anti-cancer drug called icFSP1, which sensitizes cancer cells to ferroptosis. The results of this research are published in Nature.
Jun 28, 2023
0
29